Francesca R Ogliari - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Anti-Cancer Drugs|October 10, 2020

Dabrafenib and trametinib induced pancreatitis: a case report and review of the literatureFrancesca R Ogliari, Giovanni L Rodolfo Masera, Rossana Gueli, et al.

Translational Lung Cancer Research|September 15, 2025

Adjuvant radiotherapy in the era of new peri-operative systemic treatments for surgically resected non-small-cell lung cancer: where do we stand?Francesca R Ogliari, Jarno W J Huijs, Mandy Jongbloed, et al.

Drugs|May 18, 2026

Antibody-Drug Conjugates in Non-small Cell Lung CancerLodovica Zullo, Martina Bortolot, Francesca R Ogliari, et al.

Lung Cancer (Amsterdam, Netherlands)|October 31, 2025

Overall survival in patients with non-small cell lung cancer and leptomeningeal metastases: Data from the Dutch cancer RegistryJarno W J Huijs, Francesca R Ogliari, Ronald A M Damhuis, et al.

The Lancet. Oncology|October 2, 2025

First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort studyAlessandro Di Federico, Kaiwen Wang, Monica F Chen, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Anti-Cancer Drugs|October 10, 2020

Dabrafenib and trametinib induced pancreatitis: a case report and review of the literatureFrancesca R Ogliari, Giovanni L Rodolfo Masera, Rossana Gueli, et al.

Translational Lung Cancer Research|September 15, 2025

Adjuvant radiotherapy in the era of new peri-operative systemic treatments for surgically resected non-small-cell lung cancer: where do we stand?Francesca R Ogliari, Jarno W J Huijs, Mandy Jongbloed, et al.

Drugs|May 18, 2026

Antibody-Drug Conjugates in Non-small Cell Lung CancerLodovica Zullo, Martina Bortolot, Francesca R Ogliari, et al.

Lung Cancer (Amsterdam, Netherlands)|October 31, 2025

Overall survival in patients with non-small cell lung cancer and leptomeningeal metastases: Data from the Dutch cancer RegistryJarno W J Huijs, Francesca R Ogliari, Ronald A M Damhuis, et al.

The Lancet. Oncology|October 2, 2025

First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort studyAlessandro Di Federico, Kaiwen Wang, Monica F Chen, et al.

Pageof 1